Silo Pharma (SILO) completes 1-for-15 reverse stock split and cuts authorized shares
Filing Impact
Filing Sentiment
Form Type
8-K
Rhea-AI Filing Summary
Silo Pharma, Inc. has implemented a 1-for-15 reverse stock split of its common stock, reclassifying every 15 issued and outstanding shares into one share with the same par value.
At the same time, the company proportionately reduced its authorized common stock to 6,666,667 shares. The reverse split became effective on June 2, 2026, with split-adjusted trading on Nasdaq beginning June 3, 2026 under the existing symbol SILO and a new CUSIP. Outstanding options, warrants, and equity plan reserves were adjusted proportionately, and fractional shares were rounded up to the next whole share. Existing registration statements on Forms S-1 and S-3 are automatically amended so that the amount of shares covered is reduced in line with the 1-for-15 ratio under Rule 416(b).
Positive
- None.
Negative
- None.
8-K Event Classification
4 items: 3.03, 5.03, 8.01, 9.01
4 items
Item 3.03
Material Modification to Rights of Security Holders
Securities
A change was made that materially affects the rights of existing shareholders (e.g., dividend rights, voting rights).
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Key Figures
Reverse split ratio: 1-for-15
Authorized common shares post-split: 6,666,667 shares
Effective time: 4:01 p.m. Eastern Time
+1 more
4 metrics
Reverse split ratio
1-for-15
Reverse stock split of common stock
Authorized common shares post-split
6,666,667 shares
Authorized common stock after proportionate reduction
Effective time
4:01 p.m. Eastern Time
Effective time of reverse split on June 2, 2026
Trading start on split basis
June 3, 2026
Nasdaq trading on split-adjusted basis
Key Terms
reverse stock split, Certificate of Change, equity incentive compensation plans, registration statements on Form S-1, +1 more
5 terms
reverse stock split financial
"to effectuate a 1-for-15 reverse stock split (the “Reverse Stock Split”)"
A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.
Certificate of Change regulatory
"filed a Certificate of Change (the “Certificate of Change”) with the Secretary of State"
equity incentive compensation plans financial
"and the number of shares reserved for issuance pursuant to the Company’s equity incentive compensation plans"
A plan that pays employees, executives or directors with company stock, stock options or similar ownership-based awards instead of or in addition to cash. It matters to investors because it aligns workers’ incentives with shareholder value—think of giving staff a slice of the company so they work to make the whole pie bigger—while also increasing the number of shares outstanding, which can reduce the ownership percentage and earnings per share for existing shareholders.
registration statements on Form S-1 regulatory
"The Company has a registration statements on Form S-1 (File Nos. 333-280855 and 333-291129)"
A registration statement on Form S-1 is a formal filing with the U.S. securities regulator that gives detailed information about a company planning to sell shares to the public, including its business model, finances, risks and how the offering will work. Think of it as a product brochure plus rulebook for a new stock: investors use it to check the company’s track record, judge potential rewards and risks, and decide whether the share offering fits their portfolio.
Rule 416(b) regulatory
"Pursuant to Rule 416(b) under the Securities Act of 1933, as amended"
FAQ
What reverse stock split did Silo Pharma (SILO) implement?
Silo Pharma implemented a 1-for-15 reverse stock split of its common stock. Every 15 issued and outstanding shares were automatically combined into one share, with no change to par value, simplifying the share structure and increasing the per-share trading price.
When did Silo Pharma’s (SILO) reverse stock split become effective?
The reverse stock split became effective at 4:01 p.m. Eastern Time on June 2, 2026. Silo Pharma’s common stock began trading on a split-adjusted basis on June 3, 2026, when the Nasdaq Capital Market opened under the existing SILO symbol.
What happened to Silo Pharma’s (SILO) options, warrants, and equity plans?
All outstanding options, warrants, and equity incentive plan reserves were adjusted proportionately to the 1-for-15 ratio. Both the per-share exercise prices and the number of shares issuable or reserved were recalculated to maintain equivalent economic value after the reverse stock split.
How are Silo Pharma’s (SILO) registration statements affected by the reverse split?
Silo Pharma’s active registration statements on Forms S-1 and S-3 are automatically amended under Rule 416(b). The number of undistributed shares of common stock covered by those effective registrations is proportionately reduced to reflect the 1-for-15 reverse stock split.